Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 22;107(8):e3515–e3525. doi: 10.1210/clinem/dgac166

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 4. — Comparison of hormone levels between visits 1 and 2 (n = 11). Estradiol and prolactin for visit 1 were calculated as mean of all visit 1 time points (hour 0-hour 12). Follicle-stimulating hormone (FSH) values include all FSH levels during visit 1 baseline sampling (hour 0-hour 12) and FSH levels across kisspeptin administration during visit 2 (hour 1-hour 11). FSH First 2H of Kisspeptin administration includes all FSH levels during visit 1 baseline sampling and FSH across first 2 hours of kisspeptin administration during visit 2 (hour 1-hour 3). A, FSH visit 1 vs. visit 2 restricted to first 2Hrs of kisspeptin administration; B, FSH; C, prolactin; and D, estradiol.